Pulmonary Artery Pressure monitoring system for patients with Heart Failure
- Trial ID:
- IRB-18-7211
- Thomas Heywood, M.D.
Inclusion Criteria
Patients must:- Be 18 years of age or older
- Be NYHA Class III
- Have a heart failure hospitalization within the past 12 month
- Be optimally stable on medical therapy for at least 30 days
Exclusion Criteria
Patients must not:- Have severe valvular disease that requires repair
- Have an active infection
- Have had a major cardiovascular event (e.g., unstable angina, myocardial infarction, percutaneous coronary intervention, open heart surgery, stroke, etc.) within 90 days prior to consent
- Be enrolled in another trial with an active treatment plan
Additional Info
- All patients will be implanted with the CardioMEMS™ device and will have follow-up telephone contacts post-implant at least once every two weeks for the first three months, then monthly until the 12 month follow-up visit. Office visits will occur at 6 and 12 months.
- All treatment and physician visits during this study will take place at Anderson Medical Pavilion and/or Prebys Cardiovascular.
- Search for NCT# 03387813 at www.clinicaltrials.gov for more information
- Study participation will last up to 12 months.
Contact Info:
- Clinical Research Leadership
- CRSLeadership@scrippshealth.org